mesothelin

Preliminary results released of Phase 1 clinical trial targeting mesothelin

Yesterday, at the annual meeting of the American Society of Gene and Cell Therapy in Chicago, researchers from Memorial Sloan Kettering Cancer Center released a preliminary report on their Phase 1 study into regionally delivered autologous mesothelin-targeted CAR T cells in patients with pleural mesothelioma.
Drs. Prasad Adusumilli, with co-authors Marjorie Zauderer, and Valerie Rusch (all […]


GUEST POST: An ASCO Update from Dr. Lee M. Krug, MD

The Meso Foundation is happy to present this special guest blogpost from Lee M. Krug, MD, Associate Attending Physician in the Division of Thoracic Oncology, Department of Medicine at Memorial Sloan-Kettering Cancer Center in New York, New York and Director of the Mesothelioma Program at Memorial Sloan-Kettering Cancer Center. Dr. Krug has investigated multimodality approaches […]


FROM THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION’S “MEET THE EXPERTS” SERIES: An Evening of Research Breakthroughs with Dr. Raffit Hassan

Tonight, as part of the “Meet the Experts” podcasts presented exclusively from the Meso Foundation, Dr. Raffit Hassan, Senior Investigator and Chief of the Solid Tumor Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute (NCI) and former Chair of the Meso Foundation’s Science Advisory Board, sat down with Mary Hesdorffer, […]